Danaher(DHR) Prnewswire·2025-01-09 21:15Partnership Overview - Danaher Diagnostics LLC and Danaher Ventures LLC, subsidiaries of Danaher Corporation, have formed an investment partnership with Innovaccer Inc, a leading healthcare AI company [1] - The partnership aims to accelerate the adoption of precision diagnostics by clinicians and population health teams, facilitating value-based care [2] - The collaboration seeks to improve patient outcomes and experience through novel digital and diagnostic solutions [7] Strategic Objectives - The partnership aligns with Danaher's mission to accelerate the transition to precision medicine with AI-enabled diagnostics [7] - Innovaccer's software solutions create a unified patient record to identify gaps in care, patients at risk, and appropriate interventions to improve patient outcomes [2] - The investment partnership will empower patients and speed the transition to more personalized, value-based medicine by providing healthcare providers with data and analytics for meaningful clinical insights [3] Company Statements - Danaher emphasizes its commitment to ethically using AI to develop better diagnostics, helping doctors treat patients with the right medicine at the right time [4] - Innovaccer's CEO highlights the company's mission to improve health outcomes through its data platform and AI capabilities, believing the partnership with Danaher will accelerate advancements in diagnostic and clinical AI solutions [4] About Danaher - Danaher is a global life sciences and diagnostics innovator focused on improving human health through science and technology [5] - The company's advanced science and technology enable faster, more accurate diagnoses and reduce the time and cost needed to develop life-changing therapies [5] - With approximately 63,000 associates worldwide, Danaher is committed to scientific excellence, innovation, and continuous improvement to improve quality of life for billions of people [5]